{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:38:06Z","timestamp":1791999486385,"version":"4.4.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1053\/bega.2001.0188","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:54:50Z","timestamp":1032429290000},"page":"413-431","source":"Crossref","is-referenced-by-count":57,"title":["Current role of acid suppressants in Helicobacter pylori eradication therapy"],"prefix":"10.1053","volume":"15","author":[{"given":"Joachim","family":"Labenz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/bega.2001.0188_RF1","first-page":"133","article-title":"Consequences of Helicobacter pylori cure in ulcer patients","volume":"14","author":"Labenz","year":"2000","journal-title":"Bailli\u00e8re's Clinical Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1634\/theoncologist.3-2-124","article-title":"Helicobacter pylori and gastric cancer","volume":"3","author":"Stolte","year":"1998","journal-title":"Oncologist"},{"key":"10.1053\/bega.2001.0188_RF3","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/jnci\/89.18.1350","article-title":"Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma","volume":"89","author":"Neubauer","year":"1997","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1053\/bega.2001.0188_RF4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/bmj.321.7262.659","article-title":"Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia","volume":"321","author":"Moayyedi","year":"2000","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2001.0188_RF5","first-page":"A106","article-title":"Healing of active autoimmune gastritis by eradication of Helicobacter pylori\u2013 first results of a prospective, randomized, placebo-controlled study","volume":"47","author":"Bayerd\u00f6rffer","year":"2000","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0188_RF6","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0016-5085(00)70003-5","article-title":"Therapy of Helicobacter pylori: current status and issues","volume":"118","author":"Graham","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.320.7226.31","article-title":"Regular review. Treatment of Helicobacter pylori infection","volume":"320","author":"De Boer","year":"2000","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2001.0188_RF8","first-page":"1716","article-title":"Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori","volume":"87","author":"Chiba","year":"1992","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF9","first-page":"1860","article-title":"Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial","volume":"88","author":"Peterson","year":"1993","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF10","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/0140-6736(91)93181-8","article-title":"Activity of lansoprazole against Helicobacter pylori","volume":"337","author":"Megraud","year":"1991","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0188_RF11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF01964416","article-title":"Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori","volume":"10","author":"Suerbaum","year":"1991","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1053\/bega.2001.0188_RF12","first-page":"53","article-title":"Identification of an ATPase system of Helicobacter pylori and its affection by benzimidazoles","volume":"56","author":"Mauch","year":"1993","journal-title":"Acta Gastroenterologica Belgica"},{"key":"10.1053\/bega.2001.0188_RF13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00042737-199309000-00003","article-title":"Inhibition of Helicobacter pylori urease by omeprazole","volume":"5","author":"Bugnoli","year":"1993","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2001.0188_RF14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0016-5085(94)90121-X","article-title":"The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by an urease-independent mechanism","volume":"107","author":"McGowan","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF15","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1365-2036.2000.00788.x","article-title":"Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors","volume":"14","author":"Stedman","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/BF01690512","article-title":"In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates ofHelicobacter pylori","volume":"15","author":"Alarcon","year":"1996","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1053\/bega.2001.0188_RF17","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/jac\/34.6.1025","article-title":"Additive effect of clarithromycin with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori","volume":"34","author":"Cederbrant","year":"1994","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1053\/bega.2001.0188_RF18","first-page":"S11","article-title":"Pathogenesis and virulence factors of Helicobacter pylori","volume":"16","author":"Jenks","year":"2000","journal-title":"Current Opinion in Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF19","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0016-5085(96)70056-2","article-title":"The effect of the environmental pH on the proton motive force of Helicobacter pylori","volume":"111","author":"Meyer-Rosberg","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/gast.2000.9372","article-title":"Acid-dependent adherence of Helicobacter pylori urease to diverse polysaccharides","volume":"119","author":"Icatlo","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/gut.35.4.455","article-title":"Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds","volume":"35","author":"Verd\u00fa","year":"1994","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0188_RF22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/gast.2000.9367","article-title":"Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation","volume":"119","author":"Mowat","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF23","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1128\/JCM.27.10.2328-2330.1989","article-title":"Lactobacillius acidophilus inhibits growth of Campylobacter pylori in vitro","volume":"27","author":"Bhatia","year":"1989","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1053\/bega.2001.0188_RF24","first-page":"481","article-title":"pH and Hp\u2013gastric acid secretion and Helicobacter pylori: implication for ulcer healing and eradication of the organism","volume":"88","author":"Hunt","year":"1993","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/gut.36.1.12","article-title":"Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole","volume":"36","author":"Logan","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0188_RF26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2036.1998.00310.x","article-title":"Changes in Helicobacter pylori gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease","volume":"12","author":"Stolte","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0016-5085(00)70135-1","article-title":"Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa","volume":"118","author":"Klinkenberg-Knol","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphisms associated with increased risk of gastric cancer","volume":"404","author":"El-Omar","year":"2000","journal-title":"Nature"},{"key":"10.1053\/bega.2001.0188_RF29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0016-5085(91)90199-U","article-title":"Helicobacter pylori infection in pernicious anemia: a prospective controlled study","volume":"100","author":"Fong","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/gut.33.5.597","article-title":"Subtypes of intestinal metaplasia and Helicobacter pylori","volume":"33","author":"Craanen","year":"1992","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0188_RF31","first-page":"825","article-title":"Morphology of chronic antral gastritis: relationship to age, Helicobacter pylori status and peptic ulceration","volume":"4","author":"Sobala","year":"1992","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2001.0188_RF32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/gut.33.5.617","article-title":"Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrom b-245","volume":"33","author":"Wandall","year":"1992","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0188_RF33","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1046\/j.1365-2036.1998.00425.x","article-title":"Review article: factors influencing antibiotic transfer across the gastric mucosa","volume":"12","author":"Goddard","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF34","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/gut.36.5.670","article-title":"Detection of intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine","volume":"36","author":"Atherton","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0188_RF35","first-page":"G827","article-title":"Profound increase in viscosity and aggregation of pig gastric mucin at low pH","volume":"261","author":"Bhaskar","year":"1991","journal-title":"American Journal of Physiology"},{"key":"10.1053\/bega.2001.0188_RF36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2036.1996.tb00183.x","article-title":"The effect of omeprazole on gastric juice viscosity, pH and bacterial counts","volume":"10","author":"Goddard","year":"1996","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2036.1998.00329.x","article-title":"Factors affecting solubility and penetration of clarithromycin through gastric mucus","volume":"12","author":"Gr\u00fcbel","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/39.1.5","article-title":"The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment ofHelicobacter pylori infection","volume":"39","author":"Erah","year":"1997","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1053\/bega.2001.0188_RF39","first-page":"597","article-title":"Effect of pH on the stability of amoxycillin in buffered aqueous solutions and gastric juice","volume":"1","author":"Erah","year":"1995","journal-title":"Pharmacology Science"},{"key":"10.1053\/bega.2001.0188_RF40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/00365529409105355","article-title":"The role of acid inhibition in the treatment of Helicobacter pylori infection","volume":"29","author":"Axon","year":"1994","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF41","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/BF01963775","article-title":"Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents","volume":"8","author":"Grayson","year":"1989","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1053\/bega.2001.0188_RF42","first-page":"39","article-title":"Medium-term results of oral and intravenous omeprazole\/amoxicillin H. pylori eradication therapy","volume":"89","author":"Adamek","year":"1994","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF43","first-page":"A34","article-title":"Enhanced amoxicillin uptake into the human gastric mucosa at lower gastric juice pH","volume":"104","author":"Arena","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/gut.37.1.39","article-title":"Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin","volume":"37","author":"Labenz","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0188_RF45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/gast.1996.v111.pm8690200","article-title":"Effect of omeprazole on the distribution of metronidazole, amoxicillin and clarithromycin in human gastric juice","volume":"111","author":"Goddard","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2036.1994.tb00320.x","article-title":"Scintigraphic assessment of the intragastric distribution and gastric emptying of an encapsulated drug: the effect of feeding and of a proton pump inhibitor","volume":"8","author":"Atherton","year":"1994","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF47","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1128\/AAC.37.7.1506","article-title":"Local gastric and serum amoxicillin concentrations after different oral application forms","volume":"37","author":"Cooremann","year":"1993","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1053\/bega.2001.0188_RF48","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1128\/AAC.39.9.2078","article-title":"Effect of omeprazole on concentration of clarithromycin in plasma and gastric tissue at steady state","volume":"39","author":"Gustavson","year":"1995","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1053\/bega.2001.0188_RF49","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/jac\/22.5.631","article-title":"Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones","volume":"22","author":"Grayson","year":"1988","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1053\/bega.2001.0188_RF50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2036.1998.00298.x","article-title":"Acid suppression by omeprazole does not affect orally administered metronidazole bioavailability and metabolism in healthy male volunteers","volume":"12","author":"Goddard","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(95)92962-2","article-title":"Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection","volume":"345","author":"de Boer","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0188_RF52","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0016-5085(99)70119-8","article-title":"The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies","volume":"116","author":"Lind","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2036.1994.tb00285.x","article-title":"Short report: omeprazole\u2013tetracycline combinations are inadequate as therapy for Helicobacter pylori infection","volume":"8","author":"Al-Assi","year":"1994","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF54","first-page":"635","article-title":"Effect of secretory inhibitors and cisapride on gastric volume in healthy volunteers","volume":"4","author":"Voderholzer","year":"1992","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2001.0188_RF55","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/0016-5085(95)90689-4","article-title":"Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers","volume":"108","author":"Bayerd\u00f6rffer","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF56","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2165\/00003495-199957060-00006","article-title":"A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy","volume":"57","author":"Peitz","year":"1999","journal-title":"Drugs"},{"key":"10.1053\/bega.2001.0188_RF57","first-page":"A99","article-title":"High-dose omeprazole\/amoxicillin therapy versus quadruple therapy against Helicobacter pylori resistant against both metronidazole and clarithromycin \u2013 a prospective, randomized, cross-over study","volume":"47","author":"Miehlke","year":"2000","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0188_RF58","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-2036.1998.00303.x","article-title":"US double-blind, controlled trials of omeprazole and amoxycillin for treatment of Helicobacter pylori","volume":"12","author":"Laine","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF59","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2036.1997.00169.x","article-title":"Doubling the omeprazole dose (40mg b.d. vs. 20mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients","volume":"11","author":"Labenz","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.0953-0673.1996.00303.x","article-title":"Dose\u2013response of omeprazole combined with amoxycillin on duodenal ulcer healing and eradication ofHelicobacter pylori","volume":"10","author":"Pommerien","year":"1996","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2036.1997.140316000.x","article-title":"An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively","volume":"11","author":"Miehlke","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF62","first-page":"A2047","article-title":"Triple vs. Dual therapy with lansoprazole (L), clarithromycin (C) and\/or amoxicillin (A) in the eradication of Helicobacter pylori","volume":"91","author":"Schwartz","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF63","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/00365529850166185","article-title":"Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin","volume":"33","author":"Sj\u00f6stedt","year":"1998","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF64","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1523-5378.1997.tb00076.x","article-title":"Relationship between the efficacy of amoxicillin and intragastric pH for the treatment of Helicobacter pylori infection","volume":"2","author":"Kleveland","year":"1997","journal-title":"Helicobacter"},{"key":"10.1053\/bega.2001.0188_RF65","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0009-9236(99)70017-2","article-title":"CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori","volume":"66","author":"Tangiawara","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000201215","article-title":"High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease","volume":"56","author":"Labenz","year":"1994","journal-title":"Digestion"},{"key":"10.1053\/bega.2001.0188_RF67","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2036.1997.132303000.x","article-title":"Randomized study comparing omeprazole plus amoxycillin versus omeprazole plus clarithromycin for eradication ofHelicobacter pylori","volume":"11","author":"Spinzi","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1523-5378.1997.tb00081.x","article-title":"Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review","volume":"2","author":"Pipkin","year":"1997","journal-title":"Helicobacter"},{"key":"10.1053\/bega.2001.0188_RF69","first-page":"A5","article-title":"Dual therapy of clarithromycin (CL) and omeprazole (OM) for treatment of patients with duodenal ulcers (DU) associated with H. pylori(HP) infection","volume":"37","author":"Hunt","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0188_RF70","first-page":"140","article-title":"The dose and frequency of omeprazole influence the eradication rate of dual therapy","volume":"56","author":"Logan","year":"1993","journal-title":"Acta Gastroenterologica Belgica"},{"key":"10.1053\/bega.2001.0188_RF71","first-page":"A148","article-title":"High-dose omeprazole with clarithromycin for one week. An effective dual therapy regimen for H. pylori infection","volume":"106","author":"Neri","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF72","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1056\/NEJM199302043280503","article-title":"Effect of ranitidine and amoxycillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer","volume":"328","author":"Hentschel","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2001.0188_RF73","first-page":"A140","article-title":"Efficacy and tolerability of a short-term, low-dose triple therapy for eradication of Helicobacter pylori","volume":"104","author":"Bazzoli","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF74","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1365-2036.1999.00530.x","article-title":"The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole","volume":"13","author":"Huang","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF75","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2036.1999.00542.x","article-title":"Evaluation of treatment regimens to cure Helicobacter pylori infection \u2013 a meta-analysis","volume":"13","author":"Laheij","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF76","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1365-2036.1998.00405.x","article-title":"Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori","volume":"12","author":"Pipkin","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF77","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0016-5085(97)80027-3","article-title":"What other regimens are under investigation to treat Helicobacter pylori infection ?","volume":"113","author":"Unge","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF78","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1523-5378.1996.tb00027.x","article-title":"Eradication of Helicobacter pylori using one-week triple therapies combining metronidazole with two antimicrobials: the MACH 1 study","volume":"1","author":"Lind","year":"1996","journal-title":"Helicobacter"},{"key":"10.1053\/bega.2001.0188_RF79","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/gut.41.6.735","article-title":"One week triple therapy for Helicobacter pylori: a multicentre comparative study","volume":"41","author":"Misiewicz","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0188_RF80","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1111\/j.1572-0241.1998.459_a.x","article-title":"Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy","volume":"93","author":"Adamek","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF81","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2036.1999.00526.x","article-title":"Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection \u2013 comparison with omeprazole and lansoprazole","volume":"13","author":"Miwa","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF82","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1046\/j.1365-2036.1999.00606.x","article-title":"Efficacy of two different dosage regimens of omeprazole, amoxicillin and metronidazole for the cure of Helicobacter pylori infection","volume":"13","author":"Bayerd\u00f6rffer","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF83","doi-asserted-by":"crossref","first-page":"A502","DOI":"10.1016\/S0016-5085(00)84132-3","article-title":"7-day treatment with esomeprazole-based triple therapy eradicates H. pylori(HP) and heals patients with duodenal ulcer","volume":"18","author":"Tulassay","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF84","doi-asserted-by":"crossref","first-page":"A503","DOI":"10.1016\/S0016-5085(00)84135-9","article-title":"7-day triple therapy with esomeprazole, amoxicillin and clarithromycin for H. pylori(HP) eradication in duodenal ulcer patients","volume":"118","author":"Veldhuyzen van Zanten","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0188_RF85","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1365-2036.2000.00798.x","article-title":"Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies","volume":"14","author":"Van Oijen","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF86","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2036.1998.00330.x","article-title":"Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study","volume":"12","author":"Bazzoli","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF87","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2036.1997.00230.x","article-title":"A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori","volume":"11","author":"Laine","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF88","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2036.2000.00660.x","article-title":"Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily","volume":"14","author":"Bardhan","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF89","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1046\/j.1365-2036.1999.00646.x","article-title":"Double vs single dose pantoprazole in combination with clarithromycin and amoxycillin for 7 days in eradication ofHelicobacter pylori in patients with non-ulcer dyspepsia","volume":"13","author":"Lamouliatte","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0188_RF90","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/gut.37.4.477","article-title":"Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori","volume":"37","author":"Borody","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0188_RF91","first-page":"A36","article-title":"Bismuth, metronidazole and tetracycline (BMT) + acid suppression in H. pylori eradication: a meta-analysis","volume":"39","author":"Chiba","year":"1996","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0188_RF92","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1365-2036.2000.00800.x","article-title":"Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease","volume":"14","author":"Hurenkamp","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169180190188X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169180190188X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T02:14:18Z","timestamp":1621131258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169180190188X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S152169180190188X"],"URL":"https:\/\/doi.org\/10.1053\/bega.2001.0188","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}